US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

17.86

0.0000

Post-market: 17.860.00000.00%19:30 EDT

Volume:2.13M

Turnover:38.05M

Market Cap:56.84B

PE:-56.09

High:17.89

Open:17.85

Low:17.78

Close:17.86

52wk High:19.10

52wk Low:12.99

Shares:3.18B

Float Shares:3.09B

Volume Ratio:0.91

T/O Rate:0.07%

Dividend:0.63

Dividend Rate:3.55%

EPS(TTM):-0.3184

EPS(LYR):-0.3042

ROE:-2.26%

ROA:2.69%

PB:1.19

PE(LYR):-58.70

Loading ...

Overview Company News Filings

Takeda reports new data from Phase 3 LATITUDE psoriasis studies of zasocitinib

Takeda Reports New Psoriasis Treatment Outperformed Competitor in Phase 3 Trial

MT Newswires Live

Keros Therapeutics Expects $20 Million Milestone Payment From Takeda

MT Newswires Live

Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium

MT Newswires Live

NYSE Order Imbalance 188812.0 Shares on Buy Side

THOMSON REUTERS

Takeda Pharmaceutical Company (TAK) Gets a Buy from Bank of America Securities

Takeda announces FDA acceptance of zasocitinib under priority review

Takeda's Investigational Plaque Psoriasis Drug Accepted for Priority Review by US FDA

MT Newswires Live

Market Chatter: Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House

MT Newswires Live

Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says

MT Newswires Live

Takeda Pharmaceutical Says US FDA Approves Rusfertide for Rare Type of Blood Cancer

MT Newswires Live

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition

Takeda receives FDA approval of NDA for Mimrylo

Takeda announces Japan MHLW approval for Orzeyful

Takeda Secures Japan Approval for Orzeyful to Treat Narcolepsy Type 1

MT Newswires Live

Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live

Link Bilgisayar launches TÜBİTAK-backed smart city emission mapping project

Takeda award from Veterans Affairs posted to SAM.gov site

Takeda Targets High-Need Psoriasis Niche With New Phase 3b Zasocitinib Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/TAK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":17.86,"timestamp":1790971200000,"preClose":17.86,"halted":0,"volume":2132769,"hourTrading":{"tag":"盘后","latestPrice":17.86,"preClose":17.86,"latestTime":"19:30 EDT","volume":83593,"amount":1492989.1515,"timestamp":1790983807967,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":3092000000,"shares":3182533200,"eps":-0.31842,"marketStatus":"Market Closed","change":0,"latestTime":"10-02 16:00:00 EDT","open":17.85,"high":17.89,"low":17.78,"amount":38050104.694914,"amplitude":0.006159,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.31842,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":17.86,"dividendRate":0.036456,"preHourTrading":{"tag":"盘前","latestPrice":17.8,"preClose":17.86,"latestTime":"07:47 EDT","volume":1101,"amount":19881.461639999998,"timestamp":1790941627043,"change":-0.06,"changeRate":-0.003359,"amplitude":0.023063},"postHourTrading":{"tag":"盘后","latestPrice":17.86,"preClose":17.86,"latestTime":"19:30 EDT","volume":83593,"amount":1492989.1515,"timestamp":1790983807967,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9096876230657314,"impliedVol":0.1897,"impliedVolPercentile":0.1514},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3092000000,"roa":"2.69%","roe":"-2.26%","lyrEps":-0.304241,"volumeRatio":0.9096876230657314,"shares":3182533200,"dividePrice":0.6336,"high":17.89,"amplitude":0.006159,"preClose":17.86,"low":17.78,"week52Low":12.99,"pbRate":"1.19","psRate":"1.94","week52High":19.1,"institutionHeld":0.1321,"latestPrice":17.86,"eps":-0.31842,"divideRate":0.035476,"volume":2132769,"delay":0,"ttmEps":-0.31842,"open":17.85,"prevYearClose":15.59,"prevWeekClose":18.86,"prevMonthClose":18.19,"prevQuarterClose":18.19,"fiveDayClose":18.86,"twentyDayClose":18.71,"sixtyDayClose":16.61,"earningDate":1793203200000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"date":"2026-10-29","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":null,"defaultRemindTime":1793260800000,"name":null,"time":"Pre-MKt","dateTimestamp":1793246400000,"actualEps":null},{"market":"US","date":"2026-07-30","symbol":"TAK","fiscalQuarterEnding":"2026/06","expectedEps":0.41,"name":null,"time":"","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"","actualEps":0.48},{"market":"US","date":"2026-05-13","symbol":"TAK","fiscalQuarterEnding":"2026/03","expectedEps":0.21,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":0.28},{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"Pre-MKt","dateTimestamp":1761796800000,"actualEps":0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689307200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-10-02","current":-56.089442,"percent":0.038462,"low":-61.265492,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"high":247.195474,"avg":38.356014,"sd":49.494702,"marketCap":57211764030.23},"quantilePoints":[{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68},{"date":"2026-02-13","current":78.528012,"twenty":15.819699,"median":29.842804,"eighty":45.203169,"marketCap":58174278066.56},{"date":"2026-02-20","current":80.98988,"twenty":15.819699,"median":29.842804,"eighty":45.358128,"marketCap":59032990935.72},{"date":"2026-02-27","current":81.400335,"twenty":15.819699,"median":29.842804,"eighty":45.393454,"marketCap":58849002644.08},{"date":"2026-03-06","current":79.553824,"twenty":15.819699,"median":29.842804,"eighty":45.478025,"marketCap":56940998250.88},{"date":"2026-03-13","current":79.357982,"twenty":15.819699,"median":29.842804,"eighty":45.710595,"marketCap":56281429903.04},{"date":"2026-03-20","current":80.68691,"twenty":15.819699,"median":29.842804,"eighty":45.805737,"marketCap":57640580474.28},{"date":"2026-03-27","current":81.700474,"twenty":15.819699,"median":29.842804,"eighty":45.946205,"marketCap":57787054549.19},{"date":"2026-04-02","current":82.399965,"twenty":15.819699,"median":29.842804,"eighty":46.155453,"marketCap":58414619614.42},{"date":"2026-04-10","current":80.189575,"twenty":15.819699,"median":29.842804,"eighty":46.418876,"marketCap":56894786236.46},{"date":"2026-04-17","current":78.147063,"twenty":15.819699,"median":29.842804,"eighty":46.632604,"marketCap":55443526794.1},{"date":"2026-04-24","current":74.636784,"twenty":15.819699,"median":29.842804,"eighty":46.753613,"marketCap":52882297496.5},{"date":"2026-05-01","current":73.293741,"twenty":15.819699,"median":29.842804,"eighty":47.281654,"marketCap":52807070808.15},{"date":"2026-05-08","current":72.930001,"twenty":15.819699,"median":29.842804,"eighty":47.890056,"marketCap":52641729349.45},{"date":"2026-05-15","current":43.474739,"twenty":21.105555,"median":29.8898,"eighty":48.072582,"marketCap":52716863079.61},{"date":"2026-05-22","current":42.090665,"twenty":21.242858,"median":29.981195,"eighty":48.072582,"marketCap":50702234820.63},{"date":"2026-05-29","current":42.164812,"twenty":21.619498,"median":30.013965,"eighty":48.079427,"marketCap":50785809331.9},{"date":"2026-06-05","current":40.583014,"twenty":21.679053,"median":30.061417,"eighty":48.072582,"marketCap":48640465321.16},{"date":"2026-06-12","current":41.868225,"twenty":21.919152,"median":30.109117,"eighty":48.072582,"marketCap":50028878946.35},{"date":"2026-06-18","current":41.497491,"twenty":22.002933,"median":30.148932,"eighty":48.072582,"marketCap":49432180569.37},{"date":"2026-06-26","current":-52.738505,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":49718648879.09},{"date":"2026-07-02","current":-54.677192,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":51786280766.08},{"date":"2026-07-10","current":-55.558413,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":52145787737.79},{"date":"2026-07-17","current":-56.812857,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":53292981615.83},{"date":"2026-07-24","current":-59.180349,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":55033430509.43},{"date":"2026-07-31","current":-53.86164,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":55207403658.2},{"date":"2026-08-07","current":-54.125428,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":55841298206.35},{"date":"2026-08-14","current":-54.819093,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":56217337436.1},{"date":"2026-08-21","current":-56.313893,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":57973616102.57},{"date":"2026-08-28","current":-56.66561,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":58133933551.36},{"date":"2026-09-04","current":-56.206423,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":59042664944.99},{"date":"2026-09-11","current":-55.356439,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":58736837078.32},{"date":"2026-09-18","current":-58.306959,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":61160748054.37},{"date":"2026-09-25","current":-58.316729,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":59951647155.23},{"date":"2026-10-02","current":-55.131731,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":57211764030.23}],"updateTime":1791035900539},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671550205","title":"Takeda reports new data from Phase 3 LATITUDE psoriasis studies of zasocitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2671550205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671550205?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:20","pubTimestamp":1790763647,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced new data from three Phase 3 LATITUDE psoriasis studies of zasocitinib, an investigational, next-generation, highly selective...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-reports-new-data-from-phase-3-latitude-psoriasis-studies-of-zasocitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-reports-new-data-from-phase-3-latitude-psoriasis-studies-of-zasocitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671271227","title":"Takeda Reports New Psoriasis Treatment Outperformed Competitor in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671271227","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671271227?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:12","pubTimestamp":1790755936,"startTime":"0","endTime":"0","summary":"Takeda  said Wednesday that its experimental pill zasocitinib showed superior results compared with the rival treatment deucravacitinib across the primary and key secondary endpoints in a Phase 3 trial for adults with plaque psoriasis.Over 36.5% of patients given the new medication achieved complete skin clearance at 16 weeks, compared with 13.9% of those taking the competitor drug, the company said.Takeda said 62.5% of subjects on zasocitinib saw a 90% reduction in disease severity by the 16-week mark, while the competing drug yielded a 34% success rate.The company said up to 93% of patients who achieved a response at week 24 maintained their skin-clearance results through week 52 in one Phase 3 study. Takeda also reported improvements in itching and quality of life as early as week 2 when compared with a placebo and the chronic inflammatory drug apremilast.Takeda said zasocitinib is under review by the US Food and Drug Administration and the European Medicines Agency for moderate-to-","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671024849","title":"Keros Therapeutics Expects $20 Million Milestone Payment From Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2671024849","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671024849?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:36","pubTimestamp":1790692577,"startTime":"0","endTime":"0","summary":"Keros Therapeutics  said Tuesday it expects to receive a $20 million development milestone payment under the terms of its license agreement for elritercept with partner Takeda Pharmaceutical , following the dosing of the first patient in the ELRiSE MF clinical trial.ELRiSE MF is a Phase 3, multicenter, double-blind, randomized trial to compare the efficacy and safety of elritercept with placebo in patients with myelofibrosis and anemia on concurrent ruxolitinib therapy, the company said.The global license agreement with Takeda, effective Jan. 16, 2025, covers the development, manufacture and commercialization of elritercept worldwide outside mainland China, Hong Kong and Macau.Keros received a $200 million upfront cash payment in February 2025 and is eligible for development, commercial and sales milestones potentially exceeding $1.1 billion, along with tiered royalties on net sales, the company said.Price: 11.31, Change: +0.03, Percent Change: +0.27","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","KROS","LENZ","BK4007","TAK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671142248","title":"Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium","url":"https://stock-news.laohu8.com/highlight/detail?id=2671142248","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671142248?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:31","pubTimestamp":1790692316,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks'  Datapoints and Apheris said Tuesday that AbbVie , argenx , Lundbeck, and Takeda  will join them as founding members of the Antibody Developability Consortium.The consortium is designed to help pharmaceutical and biotech companies predict manufacturability and developability risks earlier by building the field's largest standardized antibody developability dataset, according to a statement.The companies said that each founding member will contribute proprietary antibody sequences, with Ginkgo Datapoints filling any remaining capacity from publicly available sources to reach a total of 10,000 antibodies.The consortium is targeting an initial dataset by early 2027, they added.Price: 11.01, Change: +0.55, Percent Change: +5.26","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BGHQF631.EUR","FMED","FHLC","LU1061106388.HKD","ABBV","IE00B42XCP33.USD","VHT","LU1670627923.USD","BK4007","IE000BZT7R73.USD","IXJ","XLV","LU1732800096.USD","IE0004445239.USD","LU0868494708.USD","LU1585245621.USD","LU0211327993.USD","IE00B3PB1722.GBP","PJP","LU2023251221.USD","JDOC","GLAM","DNA.AU","LU0689472784.USD","LU2357627491.SGD","LU0128525929.USD","FTXH","PPH","MEDX","TAK","AGNG","IBB","LU0029864427.USD","LU0320765646.SGD","SG9999015945.SGD","BK4533","IE00BSNM7G36.USD","ARGX","IE0002141913.USD","LU0889565916.HKD","LU1670628061.USD","TBXU","IYH","TRUH","BK4534","DNA","LU0661504455.SGD","IE00BJT1NW94.SGD","IE0002270589.USD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670902354","title":"NYSE Order Imbalance 188812.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2670902354","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670902354?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:50","pubTimestamp":1790279402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nAQN2MKNH8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667662737","title":"Takeda Pharmaceutical Company (TAK) Gets a Buy from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2667662737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667662737?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:35","pubTimestamp":1789400150,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Koichi Mamegano maintained a Buy rating on Takeda Pharmaceutical Company today and set a price target of Yen6,80...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/takeda-pharmaceutical-company-tak-gets-a-buy-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/takeda-pharmaceutical-company-tak-gets-a-buy-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1791807156.HKD","LU2265009873.SGD","LU0098860793.USD","LU0256863811.USD","LU1718418525.SGD","LU0211331839.USD","LU0417517546.SGD","PGF","KBWB","LU1291159041.SGD","LU1804176565.USD","VFH","IE00B19Z3B42.SGD","BAC","BK4534","TFNS","XLF","LU0070302665.USD","LU0971096721.USD","LU0868494617.USD","LU0648001328.SGD","LU1668664300.SGD","LU0170899867.USD","UYG","IE00BKVL7J92.USD","LU1880398471.USD","LU0130518102.USD","LU0208291251.USD","LU0203345920.USD","LU0321505439.SGD","LU2133065610.SGD","BK4207","IE00BBT3K403.USD","LU2596442595.SGD","IYG","FTXO","LU0128525689.USD","BK4559","LU0306806265.USD","LU0314106906.USD","BK4553","FNCL","LU0321505868.SGD","LU1201861249.SGD","TAK","LU0149725797.USD","BK4504","IYF","IE00BZ1G4Q59.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667528706","title":"Takeda announces FDA acceptance of zasocitinib under priority review","url":"https://stock-news.laohu8.com/highlight/detail?id=2667528706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667528706?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:15","pubTimestamp":1789377307,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced that the FDA accepted its new drug application, or NDA, under priority review for zasocitinib for the treatment of adults wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-fda-acceptance-of-zasocitinib-under-priority-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-fda-acceptance-of-zasocitinib-under-priority-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","TAK","LABU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667722659","title":"Takeda's Investigational Plaque Psoriasis Drug Accepted for Priority Review by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667722659","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667722659?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:42","pubTimestamp":1789375339,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  investigational zasocitinib's new drug application for the treatment of adults with moderate-to-severe plaque psoriasis has been accepted for priority review by the US Food and Drug Administration, the company said Monday.The drug showed \"rapid, durable and consistent\" skin clearance in a phase 3 trial involving nearly 3,000 patients, the company said.Shares of the company were up 4.1% in premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4588","BK4585","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007098","title":"Market Chatter: Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007098","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007098?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:08","pubTimestamp":1788199713,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical , Bayer, CSL, and other mid-size biotech firms are set to announce new pricing deals with the White House on Monday, the Financial Times reported, citing two sources familiar with the matter.The deals will be similar to those finalized by large pharmaceutical companies in which they agreed to lower prices in exchange for tariff relief, according to the report.Takeda, Bayer, and CSL did not immediately reply to a request for comment from MT Newswires.Price: 17.99, Change: -0.05, Percent Change: -0.25","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","XBI","BK4007","BK4585","TAK","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663800423","title":"Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2663800423","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663800423?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:29","pubTimestamp":1788190151,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics'  future growth will hinge more on its wholly owned programs than on its newly approved partner therapy, with the company's first clinical readouts from its proprietary pipeline expected in H1 2027. Wedbush Securities said Monday in a report.Wedbush highlighted PN-8047, an oral version of rusfertide, a treatment recently approved for polycythemia vera and commercialized by Takeda Pharmaceutical . PN-8047 appears similarly potent and may move into a phase 2 study in 2027 if early safety and iron-lowering data are positive, the report said.Protagonist's cash position is strengthened by payments tied to rusfertide's regulatory approval, including a $200 million opt-out fee and a $75 million milestone, along with similar payments from Johnson & Johnson  for icotyde, an oral anti-inflammatory drug being developed for psoriasis and other immune conditions, the report said.Wedbush maintained its outperform rating on Protagonist stock with a $173 price target.Price: 14","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1074936037.SGD","FHLC","LU1244550494.USD","LU2602419157.SGD","IE0034235303.USD","LU0122379950.USD","SG9999013999.USD","LU1145028129.USD","IE00BDGV0183.EUR","VHT","LU2347655156.SGD","LU0426412945.USD","LU2430703251.USD","IE000BZT7R73.USD","IXJ","LU1196500208.SGD","XLV","IHE","LU1221951046.USD","LU1585245621.USD","PJP","LU0795875169.SGD","JNJ","SGXZ57979304.SGD","JDOC","LU2750360641.GBP","LU1430594728.SGD","PTGX","IE00BFTCPJ56.SGD","LU1032466523.USD","SG9999001176.SGD","FTXH","LU0432979614.USD","LU0640476718.USD","MEDX","TAK","SG9999002232.USD","IE00BLSP4452.SGD","GDOC","TRUH","BMED","LU0320765646.SGD","BK4139","IYH","LU1894683264.USD","LU0234572021.USD","LU2430703178.SGD","IE000SO60NU8.SGD","IE0002270589.USD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073421","title":"Takeda Pharmaceutical Says US FDA Approves Rusfertide for Rare Type of Blood Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073421","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073421?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:24","pubTimestamp":1788164657,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said late Friday the US Food and Drug Administration approved rusfertide for the treatment of erythrocytosis in adults with polycythemia vera, a rare type of blood cancer.The approval is supported by data from a phase 3 study that showed rusfertide plus standard of care demonstrated higher response rate, including hematocrit control, reduced phlebotomy and improved fatigue compared with placebo plus standard of care, the company said.The treatment was generally well tolerated through 52 weeks, with injection-site reactions and anemia among the most common treatment-emergent adverse events, Takeda said.The approval does not change Takeda's consolidated financial guidance for fiscal 2026, it said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4007","LABU","TAK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","BBP","SYNB","NVIB","BK4588","PTGX","BK4007","MRNX","IYH","IBB","BK4585","BK4139","GDOC","TBXU","LABU","TAK","XLVX","IDNA","RSPH","MRNY","MEDI","IEIH","PINK","LFSC","BMED","GNMX","FRTY","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016729","title":"Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016729","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016729?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:02","pubTimestamp":1787958120,"startTime":"0","endTime":"0","summary":"Takeda's treatment for erythrocytosis in adults with polycythemia vera, a form of blood cancer, received approval from the Food and Drug Administration.The company said Friday that the FDA approved its new drug application for Mimrylo, also known as rusfertide. The drug treats adults with erythrocytosis who have PV, a condition involving an abnormally high concentration of red blood cells.\"The approval of Mimrylo underscores the strength of Takeda's late-stage pipeline and our focus on developing genuinely differentiated therapies for patients who are urgently waiting for new options,\" Chief Executive Julie Kim said.The development does not impact Takeda's guidance for the current fiscal year, the company said.The agency's approval was based on data from the company's Phase 3 trial of the treatment. An open-label extension of that trial is continuing, and the company said it is engaging with international regulators about the drug.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4007","TAK","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","BBP","BMED","PINK","TBXU","XLVX","MRNY","BK4007","IYH","BK4585","PSCH","LFSC","RSPH","MRNX","IDNA","NVIB","IEIH","BK4588","TAK","GNMX","MEDI","SYNB","GDOC","TECB","FRTY","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222307","title":"Takeda announces Japan MHLW approval for Orzeyful","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222307","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222307?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:10","pubTimestamp":1787562618,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced that the Japanese Ministry of Health, Labour and Welfare, or MHLW, approved the use of Orzeyful for the treatment of narcole...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-japan-mhlw-approval-for-orzeyful-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-japan-mhlw-approval-for-orzeyful-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661722984","title":"Takeda Secures Japan Approval for Orzeyful to Treat Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2661722984","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661722984?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:38","pubTimestamp":1787557113,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  has received approval from Japan's Ministry of Health, Labour and Welfare for Orzeyful to treat narcolepsy type 1 in adults, the company said Monday.The approval was supported by data including phase 3 results showing the drug delivers statistically significant improvements in disease symptoms, Takeda said.The company expects to launch the product as quickly as possible.The drug has received similar approvals in US and China.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660493284","title":"Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660493284","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660493284?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:41","pubTimestamp":1787064070,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking lower Tuesday morning, declining 1.03% to 2,988.00 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by pharmaceutical company Takeda Pharmaceutical  and fashion platform MOGU , which rose 4.3% and 3.3% respectively. They were followed by tech company Alibaba Group  and game live-streaming platform HUYA , which were up 2.8% and 1.5% respectively.The decliners from North Asia were led by internet and data center services provider VNET Group  and semiconductor company ASE Technology , which fell 9.3% and 8.6% respectively. They were followed by tech company Baidu  and automotive marketplace Token Cat , which lost 8.5% and 5.7% respectively.From South Asia, the only gainers were lender ICICI Bank  and IT firm Infosys , which were up 0.4% and 0.1% respectively.The decliners from South Asia were led by tech conglomerate Sea  and computer hardware maker Canaan , which dropped 3.5% and 3.3% respecti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1235294995.USD","LU1861217088.USD","LU1366334651.USD","LU0175139822.USD","LU1769817096.USD","LU0541502299.USD","LU1046422090.SGD","LU0106959298.USD","SG9999002620.SGD","LU0128525689.USD","LU0516423174.USD","BK4523","LU0048597586.USD","LU2238330802.EUR","LU0918141887.USD","SG9999004360.SGD","LU0348814723.USD","BK4220","BK4600","RDY","LU0499858438.USD","LU0553294199.USD","LU0823039010.USD","BK4503","ONLN","SG9999013478.USD","LU1880383366.USD","LU0499858602.USD","LU0589944569.HKD","LU0251144936.SGD","BK4565","LU1003077747.HKD","BK4612","IE00B7N09G41.SGD","BK4557","LU0143863784.USD","LU1868837565.USD","LU0231203729.USD","BK4554","HUYA","BK4579","LU0143863198.USD","LU0541501648.USD","LU0261947096.USD","LU0307460401.USD","LU1688375341.USD","LU0345775950.USD","BK4527","LU1868837722.USD","LU1823568750.SGD","LU0264410563.USD","LU0210637038.USD","BK4533","SG9999002604.SGD","BK4526","SG9999013486.USD","IE00B3M56506.USD","LU0516422366.SGD","LU0164881194.USD","BK4535","BK4134","LU0831103253.SGD","IE00BYTNYM70.SGD","KBDU","BK4574","BK4504","BK4602","SG9999002406.SGD","SG9999002679.SGD","IE0031814969.USD","CAN","IE0034224299.USD","BK4531","LU0261950470.USD","LU0289960550.SGD","LU0516422440.USD","LU1048588211.SGD","LU2065170008.USD","LU2226246903.HKD","LU0197229882.USD","BK4551","LU0456842615.SGD","VNET","BK4007","LU1242518857.USD","IE0001KFT4U8.USD","BK4607","LU0345776255.USD","BK4585","LU0797268264.HKD","BABA","EDOG","BABU","LU0545039389.USD","LU2125910849.SGD","LU0441851309.USD","LU0251143029.SGD","BK4207","SE","LU1051769294.HKD","LU0572939691.SGD","TAK","LU1769817179.HKD","LU1115378108.SGD","LU0880133367.SGD","BK4505","BK4588","09988","BK4566","LU0328353924.USD","LU0048575426.USD","LU0536402901.SGD","LU1508157978.USD","DRGN","LU0181495838.USD","LU0572940350.SGD","SG9999004220.SGD","BK4116","BK4502","LU2663582299.SGD","SGXZ58947870.SGD","09888","BK4085","LU0310800965.SGD","BK4548","LU0640798160.USD","LU0431992006.USD","SG9999006266.SGD","BK4534","LU0348816934.USD","TLK","BK4513","LU1023057109.AUD","BK4009","LU2265009873.SGD","SG9999005177.SGD","IE00B0JY6N72.USD","LU0287142896.SGD","IE00BF5LJ272.USD","LU0708995666.HKD","BBYY","BIDG","LU0066902890.USD","LU1008478684.HKD","LU0287143357.SGD","LU0651947912.USD","SG9999001135.SGD","BK4077","LU2177674079.SGD","LU0898667661.SGD","LU0248272758.USD","LU1282648689.USD","LU2543165471.USD","LU0348744763.USD","LU0251143458.SGD","BK4552","LU0501845795.SGD","LU0516423091.SGD","LU0531971678.HKD","LU1105468828.SGD","SG9999014484.SGD","BK4614","BK4141","LU0173614495.USD","LU0738911758.USD","DRAG","LU0868486357.SGD","LU1267930656.SGD","BK4596","LU1515016050.SGD","LU1152091168.USD","IBN","KBAB","BK4587","LU0261945553.USD","LU2065171402.SGD","BK4509","BK4514","BABO","ALBmain","IE00BFMHRM44.USD","LU0333810181.USD","LU1048596156.SGD","FDNI","LU0359201612.USD","LU1839390173.USD","SG9999013460.SGD","LU2148611432.USD","ASX","LU0791590937.USD","LU0048573645.USD","LU0828237940.HKD","BK4575","LU0516422952.EUR","IE00BD6J9T35.USD","LU1323998911.USD","LU1868838027.USD","CLIX","LU0737861269.HKD","LU0359202008.SGD","LU1366334578.USD","LU2087589342.USD","LU1267930227.SGD","LU2125910500.SGD","LU1102505762.USD","BABW","BK4115","LU1242518931.SGD","LU2360107671.USD","BIDU","BK4543","LU1102505929.USD","LU2152927971.USD","LU1152091754.HKD","LU1804176565.USD","BABX","LU0918141705.HKD","LU1861220207.SGD","BK4581","LU2045819591.USD","LU0532188223.SGD","LU0348788117.USD","LU2065171311.SGD","LU0821914370.USD","TC","LU1805238398.USD","SG9999002414.USD","LU0791591158.USD","LU1046421795.USD","LU1051768304.USD","LU0072462343.USD","LU0862451753.SGD","LU1770036033.HKD","MOGU","LU0979878070.USD","BK4122","LU0949170772.SGD","INFY","BK4595","BK4170","BK4558","IE00B0JY6M65.USD","LU0067412154.USD","SG9999014492.USD","LU0661504455.SGD","LU0823038988.USD","LU0890818403.SGD","LU0651946864.USD","LU0264606111.USD","BK4538","LU1481012133.USD","BK4532","LU0047713382.USD","LU2065169927.USD","BK4524","LU0052756011.USD","LU0072913022.USD","LU2008162690.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659605909","title":"Link Bilgisayar launches TÜBİTAK-backed smart city emission mapping project","url":"https://stock-news.laohu8.com/highlight/detail?id=2659605909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659605909?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:54","pubTimestamp":1786550098,"startTime":"0","endTime":"0","summary":"An update from Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret A.S. ( ($TR:LINK) ) is now available. Link Bilgisayar Sistemleri Y...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/link-bilgisayar-launches-tubitak-backed-smart-city-emission-mapping-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/link-bilgisayar-launches-tubitak-backed-smart-city-emission-mapping-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLNK","CHNU","TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931884","title":"Takeda award from Veterans Affairs posted to SAM.gov site","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931884?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:45","pubTimestamp":1786365918,"startTime":"0","endTime":"0","summary":"A contract award dated August 7 from Department of Veterans Affairs to Takeda (TAK) Pharmaceuticals America was posted to the SAM.gov website. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-award-from-veterans-affairs-posted-to-sam-gov-site-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-award-from-veterans-affairs-posted-to-sam-gov-site-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657640129","title":"Takeda Targets High-Need Psoriasis Niche With New Phase 3b Zasocitinib Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2657640129","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657640129?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:31","pubTimestamp":1786120262,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) has launched a Phase 3b study titled “A Phas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-targets-high-need-psoriasis-niche-with-new-phase-3b-zasocitinib-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-targets-high-need-psoriasis-niche-with-new-phase-3b-zasocitinib-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":88,"code":"91000000","status":"200"}]}}